Some investigators have challenged the concept of the tumor-promoting actions of PRL, arguing that elevated PRL and/or high expression of the PRLR can actually serve as markers of favorable clinic-pathological parameters and better patient survival [41]. This evidence concerns the gene PRLR and neoplasm.